Last reviewed · How we verify

NCT01391975: SPIDA

Surveillance and Proactive Intervention for Dialysis Access

Withdrawn NA Last updated 22 March 2021
What this trial tests

NA trial testing Active ultrasound surveillance of fistula and proactive treatment of stenosis in Renal Failure. Withdrawn.

Quick facts

Lead sponsorUniversity of Hull
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingnone
Primary purposeprevention
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Hull

Who can join

18 and older, any sex, with Renal Failure or Arteriovenous Fistula. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Newly formed dialysis fistulae can often fail, and failure is usually due to narrowing of the blood vessels. Methods of detecting narrowing are available and, more importantly, can detect narrowings before a fistula fails. It is not known whether treating these narrowings will actually improve fistula survival or if the majority can be left alone. we wish to see if we can detect such narrowings with ultrasound scanning and if early detection and treatment improves patient outcomes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Pre-emptive correction for haemodialysis arteriovenous access stenosis.
    Ravani P, Quinn RR, Oliver MJ, Karsanji DJ, et al · · 2016 · cited 10× · PMID 26741512 · DOI 10.1002/14651858.cd010709.pub2

Verify or expand the search:

Other recruiting trials for Renal Failure

Currently open trials in the same condition.

Other University of Hull trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01391975.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing